Kanabo Group (STU:3WD) Equity-to-Asset: 0.86 (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kanabo Group Equity-to-Asset?

Kanabo Group STU:3WD Equity-to-Asset is 0.86 as of Jun. 2024.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kanabo Group's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €7.00 Mil. Kanabo Group's Total Assets for the quarter that ended in Jun. 2024 was €8.11 Mil. Therefore, Kanabo Group's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.86.

The historical rank and industry rank for Kanabo Group's Equity-to-Asset or its related term are showing as below:

STU:3WD's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.48
* Ranked among companies with meaningful Equity-to-Asset only.

Kanabo Group  (STU:3WD) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kanabo Group Equity-to-Asset Related Terms


Kanabo Group Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Kanabo Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kanabo Group Equity-to-Asset Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.95 -0.08 0.93 0.86 0.90

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.86 0.93 0.90 0.86

STU:3WD vs HCA, THC, EHC: Equity-to-Asset Comparison

For the Medical Care Facilities subindustry, Kanabo Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kanabo Group Equity-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kanabo Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kanabo Group's Equity-to-Asset falls into.



Kanabo Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kanabo Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=8.721/9.694
=0.90

Kanabo Group's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=7.002/8.11
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.86 mean?
Kanabo Group (STU:3WD) has a Equity-to-Asset of 0.86 as of Jun. 2024. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Kanabo Group and its competitors.
Is Kanabo Group's Equity-to-Asset too high?
Kanabo Group's current Equity-to-Asset is 0.86. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Kanabo Group's value of 0.86 is 79.2% above this industry median.
How does Kanabo Group's Equity-to-Asset compare to HCA and THC?
Kanabo Group's Equity-to-Asset of 0.86 can be compared against companies in the Healthcare Providers & Services industry. The industry median Equity-to-Asset is 0.48. Kanabo Group's value of 0.86 is 79.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kanabo Group's current Equity-to-Asset of 0.86 is 79.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Kanabo Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kanabo Group's current Equity-to-Asset is 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kanabo Group stock overvalued right now?
Kanabo Group (STU:3WD) has a current Equity-to-Asset of 0.86. The current Equity-to-Asset is 0.86 and 79.2% above the Healthcare Providers & Services industry median of 0.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Kanabo Group (STU:3WD), the current Equity-to-Asset is 0.86 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kanabo Group Business Description

Address 137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.